Diagnosis Code

D64.81 ANEMIA DUE TO ANTINEOPLASTIC CHEMOTHERAPY


Code Information

Diagnosis Code: D64.81

Short Description: Anemia due to antineoplastic chemotherapy

Long Description: Anemia due to antineoplastic chemotherapy

The code D64.81 is VALID for claim submission

Code Classification:

  • Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50–D89)
    • Aplastic and other anemias and other bone marrow failure syndromes (D60-D64)
      • Other anemias (D64)
        • D64.81 Anemia due to antineoplastic chemotherapy

Code Version: 2022 ICD-10-CM


Synonyms

  • Anemia caused by antineoplastic agent
  • Anemia due to and following chemotherapy

Diagnostic Related Group(s)

The code D64.81 is grouped in the following Diagnostic Related Group(s) (MS-DRG v39.0)
  • Red Blood Cell Disorders With Mcc (811)
  • Red Blood Cell Disorders Without Mcc (812)

References to Index of Diseases and Injuries

The code D64.81 has the following ICD-10-CM references to the Index of Diseases and Injuries
  • Inclusion Terms:
    • Antineoplastic chemotherapy induced anemia
  • Type 2 Excludes Notes:
    • anemia in neoplastic disease (@D63.0*)
    • aplastic anemia due to antineoplastic chemotherapy (@D61.1*)

Crosswalk Information

ICD-10 Code ICD-9 Code ICD-9 Description
D64.81 Right Arrow 285.3 Anemia d/t antineo chemo

This ICD-10 to ICD-9 data is based on the 2018 General Equivalency Mapping (GEM) files published by the Centers for Medicare & Medicaid Services (CMS) for informational purposes only. The data is not an ICD-10 conversion tool and doesn’t guarantee clinical accuracy.

Similar Codes

ICD-10 Code ICD-10 Description
D64 Other anemias
D64.0 Hereditary sideroblastic anemia
D64.1 Secondary sideroblastic anemia due to disease
D64.2 Secondary sideroblastic anemia due to drugs and toxins
D64.3 Other sideroblastic anemias
D64.4 Congenital dyserythropoietic anemia
D64.8 Other specified anemias
D64.89 Other specified anemias
D64.9 Anemia, unspecified


This page was last updated on: 10/1/2023